MoneyWorks4Me

Ipca Laboratories - Quaterly Results

11 Nov 2022 Evaluate
The Total revenue for the quarter ended September 2022 of  Rs. 14848.80 millions remain, more or less, the same.Net profit of the cmpany stood at Rs. 1677.80 millions for the quarter ended September 2022 a decline of -34.88% from Rs. 2576.40 millions  in the same quarter last year.A decline of 3085.30 millions was observed in the OP in the quarter ended September 2022 from 3740.90 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 14848.80 14238.40 4.29 29541.60 29024.40 1.78 53993.60 51391.60 5.06
Other Income 365.90 150.70 142.80 554.00 286.80 93.17 561.30 622.40 -9.82
PBIDT 3085.30 3740.90 -17.53 5847.90 7816.80 -25.19 12996.70 15758.20 -17.52
Interest 90.10 14.70 512.93 158.00 27.30 478.75 72.10 81.40 -11.43
PBDT 2995.20 3726.20 -19.62 5689.90 7789.50 -26.95 12924.60 15676.80 -17.56
Depreciation 549.20 505.00 8.75 1083.30 1004.60 7.83 2041.00 1877.20 8.73
PBT 2446.00 3221.20 -24.07 4606.60 6784.90 -32.11 10883.60 13799.60 -21.13
TAX 768.20 644.80 19.14 1490.60 1361.30 9.50 2174.20 2391.90 -9.10
Deferred Tax 26.70 83.00 -67.83 154.60 174.50 -11.40 201.40 -57.90 -447.84
PAT 1677.80 2576.40 -34.88 3116.00 5423.60 -42.55 8709.40 11407.70 -23.65
Equity 253.70 253.70 0.00 253.70 253.70 0.00 253.70 253.70 0.00
PBIDTM(%) 20.78 26.27 -20.92 19.80 26.93 -26.50 24.07 30.66 -21.50
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..